Fitch Ratings: How Higher Tariffs Could Impact Health Insurers

While health plans are not likely to feel the most acute effects from the Trump administration’s tariffs, they face downhill impacts from market volatility and rising costs, according to a new analysis from Fitch Ratings.

The report examines the way tariffs could affect multiple types of insurance and estimates health insurers in particular face moderate exposure to the slower economic growth and financial performance that are more indirect results of the tariffs.

Health plans benefit in this particular case from the vast majority of their operations being domestic. However, while that suggests the impacts will be fairly limited in the short term, the effects would ramp up should the tariffs remain in place for an extended period or if they evolve to be more restrictive.

As an example, tariffs on pharmaceutical products would also likely lead to short-term cost pressures on insurers, according to Fitch.

Potential inflation on healthcare costs will likely be borne by providers first, according to Fitch. So, when those organizations come to the table to negotiate reimbursement contracts, that is likely to be a key factor in those discussions.

Contracts are generally on multiyear cycles, so commercial plan contracts coming to an end in the near term could see premiums increase if providers are significantly impacted by the tariffs. For contracts with which renewals are farther out, insurers should track these trends so they can come to the table with a full view of cost pressures.

The uncertainty around the tariffs also introduces a variable into the actuarial analyses that plans use to price their products. This could lead some to overestimate the effects, or underestimate them, according to the report.

“If health insurers overestimate their increased medical costs, they will rebate any excess earnings,” the Fitch analysts said. “However, if they underestimate costs, they typically are unable to recover the losses.”

“With an eye on their competition, health insurers will likely focus on premium rate adequacy,” the researchers wrote.

Insurers that have a larger base in government insurance may see things play out differently from companies based more in the commercial sector, the report said. Should a significant economic downturn or recession follow the tariffs, that will likely shift many people to enrollment in government plans.

The tariffs also hold implications for insurers’ investments, according to the report. Changes in interest rates will impact market valuations, and bond defaults become more likely in this environment.

 

Source Link

Recommended Articles

Schumer Announces Health Care Plan

Senate Minority Leader Chuck Schumer officially unveiled Democrats’ plan for a health care vote next week, saying Thursday on the chamber floor his caucus will propose extending soon-to-expire Affordable Care Act subsidies for three years. “This is the bill, a clean three-year extension of ACA tax credits, that Democrats will bring to the floor of ...

Read More

House Votes To Pass 5-Year Hospital At Home Extension, Sending Bill To The Senate

The House of Representatives unanimously voted to pass a bill Monday that extends the Medicare hospital at home program for five years. Hospital at home providers have been mired in uncertainty for years. Though Congress has repeatedly extended hospital at home flexibilities, it often only does so for a handful of months at a time. ...

Read More

Lobbyists Are Salivating For More Of Trump’s Drug Price Deals

Lobbyists for some of the world’s largest drug companies are parading a new pricing deal in the U.K. as a model the rest of Europe should emulate if it wants to keep drugmakers from bailing for America. To President Donald Trump and the lobbyists’ delight, British officials agreed to spend 25 percent more on new ...

Read More

Senate Barrels Toward Failure On Health Care

Senators have about a week before they’re set to vote on soon-to-expire Affordable Care Act subsidies. Most of them already believe the chances for a bipartisan breakthrough by then are roughly zero. There’s no clear momentum for any plan that would avoid a lapse in tax credits that could raise insurance premiums for 20 million ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square